Rachel Rothe Bishop
CIK 1609146 · View on SEC EDGAR ↗
Insider
First SEC filing: Nov. 4, 2022 · Latest: Nov. 4, 2022
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 27 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 24, 2025 | SBH | M | 15,470 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Jan. 24, 2025 | SBH | A | 14,532 | — | — | 14,532 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 24, 2025 | SBH | M | 15,470 | — | — | 21,699 Direct | +248.35% | Acquired | (price as of 2026-08-21) |
| Jan. 25, 2024 | SBH | A | 15,470 | — | — | 15,470 Direct | — | Acquired | (price as of 2026-08-21) |
| Nov. 15, 2023 | SBH | M | 6,229 | — | — | 6,229 Direct | — | Acquired | (price as of 2026-08-21) |
| Nov. 15, 2023 | SBH | M | 6,229 | — | — | 6,229 Direct | -50.00% | Disposed | (price as of 2026-08-21) |
| Nov. 2, 2022 | SBH | A | 12,458 | — | — | 12,458 Direct | — | Acquired | (price as of 2026-08-21) |
| March 5, 2022 | REYN | M | 1,717 | — | — | 1,718 Direct | -49.99% | Disposed | (price as of 2026-08-21) |
| March 5, 2022 | REYN | F | 433 | $30.48 | $13,198 | 8,271 Direct | -4.97% | Disposed | -16.3% (price as of 2026-08-21) |
| March 5, 2022 | REYN | M | 1,717 | — | — | 8,704 Direct | +24.57% | Acquired | (price as of 2026-08-21) |
| Feb. 4, 2022 | REYN | M | 2,641 | — | — | 2,641 Direct | -50.00% | Disposed | (price as of 2026-08-21) |
| Feb. 4, 2022 | REYN | F | 687 | $30.14 | $20,706 | 6,987 Direct | -8.95% | Disposed | -15.4% (price as of 2026-08-21) |
| Feb. 4, 2022 | REYN | M | 2,641 | — | — | 7,674 Direct | +52.47% | Acquired | (price as of 2026-08-21) |
| Feb. 1, 2022 | REYN | A | 11,785 | — | — | 11,785 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 1, 2022 | REYN | M | 3,102 | — | — | 6,205 Direct | -33.33% | Disposed | (price as of 2026-08-21) |
| Feb. 1, 2022 | REYN | F | 1,011 | $30.27 | $30,603 | 5,033 Direct | -16.73% | Disposed | -15.7% (price as of 2026-08-21) |
| Feb. 1, 2022 | REYN | M | 3,102 | — | — | 6,044 Direct | +105.44% | Acquired | (price as of 2026-08-21) |
| March 5, 2021 | REYN | M | 1,717 | — | — | 3,435 Direct | -33.33% | Disposed | (price as of 2026-08-21) |
| March 5, 2021 | REYN | F | 503 | $27.97 | $14,069 | 2,942 Direct | -14.60% | Disposed | -8.8% (price as of 2026-08-21) |
| March 5, 2021 | REYN | M | 1,717 | — | — | 3,445 Direct | +99.36% | Acquired | (price as of 2026-08-21) |
| Feb. 4, 2021 | REYN | M | 2,641 | — | — | 5,282 Direct | -33.33% | Disposed | (price as of 2026-08-21) |
| Feb. 4, 2021 | REYN | F | 913 | $29.56 | $26,988 | 1,728 Direct | -34.57% | Disposed | -13.7% (price as of 2026-08-21) |
| Feb. 4, 2021 | REYN | M | 2,641 | — | — | 2,641 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 1, 2021 | REYN | A | 9,307 | — | — | 9,307 Direct | — | Acquired | (price as of 2026-08-21) |
| March 5, 2020 | REYN | A | 5,152 | — | — | 5,152 Direct | — | Acquired | (price as of 2026-08-21) |
| March 5, 2020 | REYN | A | 5,152 | — | — | 5,152 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 4, 2020 | REYN | A | 7,923 | — | — | 7,923 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 24, 2025 | SBH | Restricted stock units | Common Stock (15,470) | — | — | 15,470 | Disposed |
| Jan. 24, 2025 | SBH | Restricted stock units [F1] | Common Stock (14,532) | — | — | 14,532 | Acquired |
| Jan. 25, 2024 | SBH | Restricted stock units [F1] | Common Stock (15,470) | — | — | 15,470 | Acquired |
| Nov. 15, 2023 | SBH | Restricted stock units | Common Stock (6,229) | — | — | 6,229 | Disposed |
| Nov. 2, 2022 | SBH | Restricted stock units [F1] | Common Stock (12,458) | — | — | 12,458 | Acquired |
| March 5, 2022 | REYN | Restricted Stock Units | Common Stock (1,717) | — | — | 1,717 | Disposed |
| Feb. 4, 2022 | REYN | Restricted Stock Units | Common Stock (2,641) | — | — | 2,641 | Disposed |
| Feb. 1, 2022 | REYN | Restricted Stock Units | Common Stock (11,785) | — | — | 11,785 | Acquired |
| Feb. 1, 2022 | REYN | Restricted Stock Units | Common Stock (3,102) | — | — | 3,102 | Disposed |
| March 5, 2021 | REYN | Restricted Stock Units | Common Stock (1,717) | — | — | 1,717 | Disposed |
| Feb. 4, 2021 | REYN | Restricted Stock Units | Common Stock (2,641) | — | — | 2,641 | Disposed |
| Feb. 1, 2021 | REYN | Restricted Stock Units | Common Stock (9,307) | — | — | 9,307 | Acquired |
| March 5, 2020 | REYN | Restricted Stock Units | Common Stock (5,152) | — | — | 5,152 | Acquired |
| March 5, 2020 | REYN | Performance Share Units | Common Stock (5,152) | — | — | 5,152 | Acquired |
| Feb. 4, 2020 | REYN | Restricted Stock Units | Common Stock (7,923) | — | — | 7,923 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $558,417 | — | $755,976 | — | $439,195 | — | $97,912 | $1,851,500 |
| 2023 | $539,667 | — | $730,338 | — | $589,316 | — | $84,545 | $1,943,866 |
| 2022 | $518,750 | — | $708,750 | — | $219,172 | — | $58,204 | $1,504,876 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.